nodes	percent_of_prediction	percent_of_DWPC	metapath
Etonogestrel—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0304	0.332	CbGbCtD
Etonogestrel—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0282	0.308	CbGbCtD
Etonogestrel—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.013	0.142	CbGbCtD
Etonogestrel—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0119	0.13	CbGbCtD
Etonogestrel—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.0081	0.0885	CbGbCtD
Etonogestrel—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000689	0.000759	CcSEcCtD
Etonogestrel—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000689	0.000758	CcSEcCtD
Etonogestrel—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000687	0.000756	CcSEcCtD
Etonogestrel—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000687	0.000756	CcSEcCtD
Etonogestrel—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000686	0.000755	CcSEcCtD
Etonogestrel—Headache—Tretinoin—peripheral nervous system neoplasm	0.000685	0.000754	CcSEcCtD
Etonogestrel—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000685	0.000754	CcSEcCtD
Etonogestrel—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000685	0.000754	CcSEcCtD
Etonogestrel—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000683	0.000752	CcSEcCtD
Etonogestrel—Constipation—Vincristine—peripheral nervous system neoplasm	0.000683	0.000752	CcSEcCtD
Etonogestrel—Pain—Vincristine—peripheral nervous system neoplasm	0.000683	0.000752	CcSEcCtD
Etonogestrel—Pain in extremity—Doxorubicin—peripheral nervous system neoplasm	0.000683	0.000752	CcSEcCtD
Etonogestrel—Rash—Melphalan—peripheral nervous system neoplasm	0.000681	0.000749	CcSEcCtD
Etonogestrel—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00068	0.000749	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000678	0.000746	CcSEcCtD
Etonogestrel—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000673	0.000741	CcSEcCtD
Etonogestrel—Migraine—Doxorubicin—peripheral nervous system neoplasm	0.000672	0.00074	CcSEcCtD
Etonogestrel—Affect lability—Doxorubicin—peripheral nervous system neoplasm	0.000672	0.00074	CcSEcCtD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.00067	0.000738	CcSEcCtD
Etonogestrel—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000667	0.000734	CcSEcCtD
Etonogestrel—Breast disorder—Epirubicin—peripheral nervous system neoplasm	0.000667	0.000734	CcSEcCtD
Etonogestrel—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000659	0.000725	CcSEcCtD
Etonogestrel—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000659	0.000725	CcSEcCtD
Etonogestrel—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000655	0.000721	CcSEcCtD
Etonogestrel—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000655	0.000721	CcSEcCtD
Etonogestrel—Nausea—Topotecan—peripheral nervous system neoplasm	0.000655	0.000721	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000653	0.000719	CcSEcCtD
Etonogestrel—Gastritis—Epirubicin—peripheral nervous system neoplasm	0.000653	0.000719	CcSEcCtD
Etonogestrel—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00065	0.000715	CcSEcCtD
Etonogestrel—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00065	0.000715	CcSEcCtD
Etonogestrel—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000647	0.000712	CcSEcCtD
Etonogestrel—Mood swings—Doxorubicin—peripheral nervous system neoplasm	0.000647	0.000712	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000644	0.000708	CcSEcCtD
Etonogestrel—Infection—Etoposide—peripheral nervous system neoplasm	0.000643	0.000708	CcSEcCtD
Etonogestrel—Abdominal distension—Epirubicin—peripheral nervous system neoplasm	0.000642	0.000707	CcSEcCtD
Etonogestrel—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000642	0.000706	CcSEcCtD
Etonogestrel—Nausea—Melphalan—peripheral nervous system neoplasm	0.000641	0.000706	CcSEcCtD
Etonogestrel—Asthma—Epirubicin—peripheral nervous system neoplasm	0.000638	0.000702	CcSEcCtD
Etonogestrel—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000634	0.000698	CcSEcCtD
Etonogestrel—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000632	0.000695	CcSEcCtD
Etonogestrel—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000632	0.000695	CcSEcCtD
Etonogestrel—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000629	0.000692	CcSEcCtD
Etonogestrel—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	0.000617	0.000679	CcSEcCtD
Etonogestrel—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000617	0.000679	CcSEcCtD
Etonogestrel—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000614	0.000676	CcSEcCtD
Etonogestrel—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.000614	0.000675	CcSEcCtD
Etonogestrel—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000612	0.000673	CcSEcCtD
Etonogestrel—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000611	0.000672	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.00061	0.000671	CcSEcCtD
Etonogestrel—Gastritis—Doxorubicin—peripheral nervous system neoplasm	0.000604	0.000665	CcSEcCtD
Etonogestrel—Pain—Cisplatin—peripheral nervous system neoplasm	0.000604	0.000665	CcSEcCtD
Etonogestrel—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.000597	0.000657	CcSEcCtD
Etonogestrel—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000595	0.000655	CcSEcCtD
Etonogestrel—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.000594	0.000654	CcSEcCtD
Etonogestrel—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.000593	0.000653	CcSEcCtD
Etonogestrel—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.00059	0.00065	CcSEcCtD
Etonogestrel—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.000589	0.000649	CcSEcCtD
Etonogestrel—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000589	0.000648	CcSEcCtD
Etonogestrel—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000587	0.000646	CcSEcCtD
Etonogestrel—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000582	0.000641	CcSEcCtD
Etonogestrel—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000581	0.00064	CcSEcCtD
Etonogestrel—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000581	0.000639	CcSEcCtD
Etonogestrel—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.000577	0.000635	CcSEcCtD
Etonogestrel—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000575	0.000633	CcSEcCtD
Etonogestrel—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000573	0.000631	CcSEcCtD
Etonogestrel—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000569	0.000626	CcSEcCtD
Etonogestrel—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000569	0.000626	CcSEcCtD
Etonogestrel—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000569	0.000626	CcSEcCtD
Etonogestrel—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000568	0.000625	CcSEcCtD
Etonogestrel—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000567	0.000624	CcSEcCtD
Etonogestrel—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000564	0.000621	CcSEcCtD
Etonogestrel—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000563	0.000619	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000559	0.000615	CcSEcCtD
Etonogestrel—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000558	0.000615	CcSEcCtD
Etonogestrel—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000558	0.000614	CcSEcCtD
Etonogestrel—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000558	0.000614	CcSEcCtD
Etonogestrel—Pain—Etoposide—peripheral nervous system neoplasm	0.000553	0.000609	CcSEcCtD
Etonogestrel—Constipation—Etoposide—peripheral nervous system neoplasm	0.000553	0.000609	CcSEcCtD
Etonogestrel—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000553	0.000609	CcSEcCtD
Etonogestrel—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.000552	0.000608	CcSEcCtD
Etonogestrel—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000549	0.000604	CcSEcCtD
Etonogestrel—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000548	0.000604	CcSEcCtD
Etonogestrel—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000547	0.000602	CcSEcCtD
Etonogestrel—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000545	0.0006	CcSEcCtD
Etonogestrel—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000537	0.000591	CcSEcCtD
Etonogestrel—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000534	0.000588	CcSEcCtD
Etonogestrel—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000534	0.000587	CcSEcCtD
Etonogestrel—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000533	0.000587	CcSEcCtD
Etonogestrel—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000531	0.000585	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000529	0.000583	CcSEcCtD
Etonogestrel—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000528	0.000582	CcSEcCtD
Etonogestrel—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000527	0.00058	CcSEcCtD
Etonogestrel—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000526	0.000579	CcSEcCtD
Etonogestrel—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000526	0.000579	CcSEcCtD
Etonogestrel—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000523	0.000575	CcSEcCtD
Etonogestrel—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000522	0.000575	CcSEcCtD
Etonogestrel—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.00052	0.000573	CcSEcCtD
Etonogestrel—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000519	0.000572	CcSEcCtD
Etonogestrel—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000516	0.000568	CcSEcCtD
Etonogestrel—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000514	0.000566	CcSEcCtD
Etonogestrel—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000513	0.000565	CcSEcCtD
Etonogestrel—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000512	0.000564	CcSEcCtD
Etonogestrel—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000512	0.000563	CcSEcCtD
Etonogestrel—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000512	0.000563	CcSEcCtD
Etonogestrel—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000512	0.000563	CcSEcCtD
Etonogestrel—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000511	0.000562	CcSEcCtD
Etonogestrel—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000508	0.000559	CcSEcCtD
Etonogestrel—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000508	0.000559	CcSEcCtD
Etonogestrel—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000507	0.000558	CcSEcCtD
Etonogestrel—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000507	0.000558	CcSEcCtD
Etonogestrel—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000504	0.000555	CcSEcCtD
Etonogestrel—Rash—Vincristine—peripheral nervous system neoplasm	0.000504	0.000555	CcSEcCtD
Etonogestrel—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000503	0.000554	CcSEcCtD
Etonogestrel—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000502	0.000552	CcSEcCtD
Etonogestrel—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000501	0.000551	CcSEcCtD
Etonogestrel—Headache—Vincristine—peripheral nervous system neoplasm	0.000501	0.000551	CcSEcCtD
Etonogestrel—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000494	0.000544	CcSEcCtD
Etonogestrel—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000493	0.000542	CcSEcCtD
Etonogestrel—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000492	0.000542	CcSEcCtD
Etonogestrel—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000483	0.000532	CcSEcCtD
Etonogestrel—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000477	0.000525	CcSEcCtD
Etonogestrel—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000477	0.000525	CcSEcCtD
Etonogestrel—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000475	0.000523	CcSEcCtD
Etonogestrel—Nausea—Vincristine—peripheral nervous system neoplasm	0.000475	0.000522	CcSEcCtD
Etonogestrel—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000474	0.000521	CcSEcCtD
Etonogestrel—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000472	0.00052	CcSEcCtD
Etonogestrel—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.00047	0.000517	CcSEcCtD
Etonogestrel—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000469	0.000516	CcSEcCtD
Etonogestrel—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000467	0.000514	CcSEcCtD
Etonogestrel—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000464	0.000511	CcSEcCtD
Etonogestrel—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000464	0.000511	CcSEcCtD
Etonogestrel—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000463	0.00051	CcSEcCtD
Etonogestrel—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000463	0.00051	CcSEcCtD
Etonogestrel—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000461	0.000508	CcSEcCtD
Etonogestrel—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000458	0.000504	CcSEcCtD
Etonogestrel—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000455	0.000501	CcSEcCtD
Etonogestrel—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000451	0.000497	CcSEcCtD
Etonogestrel—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000449	0.000494	CcSEcCtD
Etonogestrel—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000447	0.000492	CcSEcCtD
Etonogestrel—Rash—Cisplatin—peripheral nervous system neoplasm	0.000445	0.00049	CcSEcCtD
Etonogestrel—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000445	0.00049	CcSEcCtD
Etonogestrel—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000445	0.000489	CcSEcCtD
Etonogestrel—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000445	0.000489	CcSEcCtD
Etonogestrel—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000443	0.000487	CcSEcCtD
Etonogestrel—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000442	0.000486	CcSEcCtD
Etonogestrel—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000438	0.000482	CcSEcCtD
Etonogestrel—Tension—Epirubicin—peripheral nervous system neoplasm	0.000436	0.00048	CcSEcCtD
Etonogestrel—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000432	0.000475	CcSEcCtD
Etonogestrel—Back pain—Epirubicin—peripheral nervous system neoplasm	0.00043	0.000473	CcSEcCtD
Etonogestrel—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000429	0.000472	CcSEcCtD
Etonogestrel—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000428	0.000471	CcSEcCtD
Etonogestrel—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000427	0.00047	CcSEcCtD
Etonogestrel—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000427	0.00047	CcSEcCtD
Etonogestrel—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00042	0.000462	CcSEcCtD
Etonogestrel—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000418	0.00046	CcSEcCtD
Etonogestrel—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000414	0.000456	CcSEcCtD
Etonogestrel—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000412	0.000454	CcSEcCtD
Etonogestrel—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000412	0.000453	CcSEcCtD
Etonogestrel—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000411	0.000453	CcSEcCtD
Etonogestrel—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000411	0.000453	CcSEcCtD
Etonogestrel—Rash—Etoposide—peripheral nervous system neoplasm	0.000408	0.000449	CcSEcCtD
Etonogestrel—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000408	0.000449	CcSEcCtD
Etonogestrel—Headache—Etoposide—peripheral nervous system neoplasm	0.000405	0.000446	CcSEcCtD
Etonogestrel—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000405	0.000446	CcSEcCtD
Etonogestrel—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000404	0.000444	CcSEcCtD
Etonogestrel—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000401	0.000441	CcSEcCtD
Etonogestrel—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000399	0.00044	CcSEcCtD
Etonogestrel—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000398	0.000438	CcSEcCtD
Etonogestrel—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000395	0.000435	CcSEcCtD
Etonogestrel—Cough—Epirubicin—peripheral nervous system neoplasm	0.000388	0.000427	CcSEcCtD
Etonogestrel—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000385	0.000424	CcSEcCtD
Etonogestrel—Nausea—Etoposide—peripheral nervous system neoplasm	0.000384	0.000423	CcSEcCtD
Etonogestrel—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000384	0.000422	CcSEcCtD
Etonogestrel—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000382	0.00042	CcSEcCtD
Etonogestrel—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000378	0.000417	CcSEcCtD
Etonogestrel—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000378	0.000417	CcSEcCtD
Etonogestrel—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000377	0.000415	CcSEcCtD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000376	0.000414	CcSEcCtD
Etonogestrel—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000374	0.000412	CcSEcCtD
Etonogestrel—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000371	0.000408	CcSEcCtD
Etonogestrel—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000363	0.000399	CcSEcCtD
Etonogestrel—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000363	0.000399	CcSEcCtD
Etonogestrel—Infection—Epirubicin—peripheral nervous system neoplasm	0.00036	0.000397	CcSEcCtD
Etonogestrel—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000359	0.000395	CcSEcCtD
Etonogestrel—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000356	0.000392	CcSEcCtD
Etonogestrel—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000356	0.000392	CcSEcCtD
Etonogestrel—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000355	0.000391	CcSEcCtD
Etonogestrel—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000352	0.000388	CcSEcCtD
Etonogestrel—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.00035	0.000385	CcSEcCtD
Etonogestrel—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.00035	0.000385	CcSEcCtD
Etonogestrel—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000349	0.000384	CcSEcCtD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000348	0.000383	CcSEcCtD
Etonogestrel—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000346	0.000381	CcSEcCtD
Etonogestrel—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000346	0.000381	CcSEcCtD
Etonogestrel—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000336	0.00037	CcSEcCtD
Etonogestrel—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000336	0.00037	CcSEcCtD
Etonogestrel—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000333	0.000367	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000331	0.000364	CcSEcCtD
Etonogestrel—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000329	0.000362	CcSEcCtD
Etonogestrel—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000328	0.000361	CcSEcCtD
Etonogestrel—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000326	0.000359	CcSEcCtD
Etonogestrel—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000326	0.000359	CcSEcCtD
Etonogestrel—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000323	0.000355	CcSEcCtD
Etonogestrel—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.00032	0.000352	CcSEcCtD
Etonogestrel—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000319	0.000352	CcSEcCtD
Etonogestrel—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000315	0.000347	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000313	0.000345	CcSEcCtD
Etonogestrel—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000313	0.000344	CcSEcCtD
Etonogestrel—Constipation—Epirubicin—peripheral nervous system neoplasm	0.00031	0.000341	CcSEcCtD
Etonogestrel—Pain—Epirubicin—peripheral nervous system neoplasm	0.00031	0.000341	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000306	0.000337	CcSEcCtD
Etonogestrel—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000304	0.000334	CcSEcCtD
Etonogestrel—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000301	0.000332	CcSEcCtD
Etonogestrel—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000299	0.000329	CcSEcCtD
Etonogestrel—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000298	0.000328	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000297	0.000327	CcSEcCtD
Etonogestrel—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000295	0.000325	CcSEcCtD
Etonogestrel—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000292	0.000321	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.00029	0.000319	CcSEcCtD
Etonogestrel—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000289	0.000319	CcSEcCtD
Etonogestrel—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000288	0.000317	CcSEcCtD
Etonogestrel—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000287	0.000316	CcSEcCtD
Etonogestrel—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000287	0.000316	CcSEcCtD
Etonogestrel—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000287	0.000316	CcSEcCtD
Etonogestrel—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000287	0.000316	CcSEcCtD
Etonogestrel—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000277	0.000304	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000274	0.000302	CcSEcCtD
Etonogestrel—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000267	0.000294	CcSEcCtD
Etonogestrel—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000267	0.000294	CcSEcCtD
Etonogestrel—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000265	0.000292	CcSEcCtD
Etonogestrel—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000265	0.000292	CcSEcCtD
Etonogestrel—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.00026	0.000287	CcSEcCtD
Etonogestrel—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000257	0.000283	CcSEcCtD
Etonogestrel—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000248	0.000273	CcSEcCtD
Etonogestrel—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000247	0.000272	CcSEcCtD
Etonogestrel—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000241	0.000265	CcSEcCtD
Etonogestrel—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.00024	0.000264	CcSEcCtD
Etonogestrel—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000237	0.000261	CcSEcCtD
Etonogestrel—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000231	0.000254	CcSEcCtD
Etonogestrel—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.00023	0.000253	CcSEcCtD
Etonogestrel—Rash—Epirubicin—peripheral nervous system neoplasm	0.000229	0.000252	CcSEcCtD
Etonogestrel—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000229	0.000252	CcSEcCtD
Etonogestrel—Headache—Epirubicin—peripheral nervous system neoplasm	0.000227	0.00025	CcSEcCtD
Etonogestrel—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000222	0.000244	CcSEcCtD
Etonogestrel—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000215	0.000237	CcSEcCtD
Etonogestrel—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000213	0.000235	CcSEcCtD
Etonogestrel—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000212	0.000233	CcSEcCtD
Etonogestrel—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000211	0.000233	CcSEcCtD
Etonogestrel—Headache—Doxorubicin—peripheral nervous system neoplasm	0.00021	0.000231	CcSEcCtD
Etonogestrel—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000199	0.000219	CcSEcCtD
